Delivery Order SPE2DB20D1109-SPE2DB25FP61S
- Not listed
- The Defense Logistics Agency awarded a $24,644.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. Performance will be executed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $37,836.27 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a $27,596 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and is scheduled for completion by July 30, 2025. The vaccine product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a $10,348.50 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 21, 2025, with completion targeted for August 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems...
- The Defense Logistics Agency awarded a $2,759.60 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $1,210.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of TYPHIM VI 25 mcg/0.5 mL vial (10 mL). This is a non-set-aside competitively awarded contract with an ultimate completion date of July 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $13,798.00 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 20, 2025. This firm fixed-price contract, awarded on August 19, 2025, utilizes a competitive delivery order mechanism with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $12,086.06 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This firm fixed price, non-set-aside delivery order was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a $13,496.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vials (10 mL) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside award was competitively procured and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a delivery order under a larger indefinite delivery vehicle, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,724.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP61SDelivery Order
The Defense Logistics Agency awarded a $13,798 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract for a typhoid vaccine product. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor and critical federal medical procurement vendor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026. That prime contract enables AmerisourceBergen to supply a wide range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide, including services to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal portfolio demonstrates its capability to fulfill diverse medical supply requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 8/21/25 |